Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Importance of Early Diagnosis and Intervention in Chronic Kidney Disease: Calls-to-Action from Nephrologists Based Mainly in Central/Eastern Europe.
Covic A, Säemann M, Filipov J, Gellert R, Gobin N, Jelaković B, Kabulbayev K, Luman M, Miglinas M, Mosenzon O, Okša A, Radovic M, Rozen-Zvi B, Ziediņa I, Tesar V. Covic A, et al. Among authors: tesar v. Kidney Blood Press Res. 2024;49(1):218-227. doi: 10.1159/000538165. Epub 2024 Mar 5. Kidney Blood Press Res. 2024. PMID: 38442701 Free article. Review.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. Among authors: tesar v. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Corrigendum to "KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis." Kidney Int. 2024;105(3S):S71-S116.
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Int. 2024 May 8:S0085-2538(24)00266-7. doi: 10.1016/j.kint.2024.04.003. Online ahead of print. Kidney Int. 2024. PMID: 38739061 Free article. No abstract available.
Corrigendum to "Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis." Kidney Int. 2024;105(3):447-449.
Floege J, Jayne DRW, Sanders JF, Tesar V, Balk EM, Gordon CE, Adam G, Tonelli MA, Cheung M, Earley A, Rovin BH. Floege J, et al. Among authors: tesar v. Kidney Int. 2024 May 8:S0085-2538(24)00267-9. doi: 10.1016/j.kint.2024.04.004. Online ahead of print. Kidney Int. 2024. PMID: 38739060 Free article. No abstract available.
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis.
Scott J, White A, Walsh C, Aslett L, Rutherford MA, Ng J, Judge C, Sebastian K, O'Brien S, Kelleher J, Power J, Conlon N, Moran SM, Luqmani RA, Merkel PA, Tesar V, Hruskova Z, Little MA. Scott J, et al. Among authors: tesar v. RMD Open. 2024 Apr 30;10(2):e003962. doi: 10.1136/rmdopen-2023-003962. RMD Open. 2024. PMID: 38688690 Free PMC article.
Capacity for the management of kidney failure in the International Society of Nephrology Eastern and Central Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).
Alparslan C, Malyszko J, Caskey FJ, Aleckovic-Halilovic M, Hrušková Z, Arruebo S, Bello AK, Damster S, Donner JA, Jha V, Johnson DW, Levin A, Malik C, Nangaku M, Okpechi IG, Tonelli M, Ye F, Tesar V, Racki S; Regional Board and ISN-GKHA Team Authors. Alparslan C, et al. Among authors: tesar v. Kidney Int Suppl (2011). 2024 Apr;13(1):29-42. doi: 10.1016/j.kisu.2024.01.006. Epub 2024 Apr 8. Kidney Int Suppl (2011). 2024. PMID: 38618499 Free PMC article. Review.
584 results